Innate Pharma

Innate Pharma specializes in immuno-oncology, a new therapeutic field that is changing cancer treatment by mobilizing the power of the body’s immune system to recognize and kill cancer cells. The Company’s aim is to become a commercial stage biopharmaceutical company in the area of immunotherapy and focused on serious unmet medical needs in cancer. Innate Pharma has pioneered the discovery and development of checkpoint inhibitors to activate the innate immune system. Innate Pharma's innovative approach has resulted in three first-in-class, clinical-stage antibodies targeting natural killer cell receptors that may address a broad range of solid and hematological cancer indications.
Type
Public
HQ
Marseille, FR
Founded
1999
Size (employees)
127 (est)
Innate Pharma was founded in 1999 and is headquartered in Marseille, FR

Key People/Management at Innate Pharma

Herve Brailly

Herve Brailly

CEO
Marcel ROZENCWEIG

Marcel ROZENCWEIG

CMO

Innate Pharma Office Locations

Innate Pharma has an office in Marseille

Innate Pharma Financials and Metrics

Innate Pharma Financials

EUR

Market capitalization (17-Oct-2017)

555.1 m

Closing share price (17-Oct-2017)

10.3
Innate Pharma's current market capitalization is €555.1 m.
Show all financial metrics

Innate Pharma Market Value History

Traffic Overview of Innate Pharma

Innate Pharma Online and Social Media Presence

Innate Pharma Company Life and Culture

You may also be interested in